neurotensin (Human) [5729]



neurotensin (Human)


SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CC(C)C)C(=O)O
InChIKey PCJGZPGTCUMMOT-ISULXFBGSA-N
Sequence XLYENKPRRPYIL
HELM PEPTIDE1{[Glp].L.Y.E.N.K.P.R.R.P.Y.I.L}$$$$

Chemical Properties

Hydrogen bond acceptors 21
Hydrogen bond donors 21
Rotatable bonds 50
Log P -3.809
Molecular weight (Da) 1671.9
Stereochemistry info partial


Bioactivities

Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database
Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database

neurotensin (Human)


Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0


Compound is not listed as a drug.